Bio-Rad Laboratories Net Profit Margin 2010-2022 | BIO.B

Current and historical net profit margin for Bio-Rad Laboratories (BIO.B) from 2010 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue. Bio-Rad Laboratories net profit margin for the three months ending March 31, 2022 was .
Bio-Rad Laboratories Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $2.90B $-0.10B -3.52%
2021-12-31 $2.92B $4.25B 145.23%
2021-09-30 $2.98B $6.66B 223.42%
2021-06-30 $2.88B $4.05B 140.45%
2021-03-31 $2.70B $4.10B 151.68%
2020-12-31 $2.55B $3.81B 149.49%
2020-09-30 $2.38B $3.52B 147.90%
2020-06-30 $2.29B $1.95B 84.83%
2020-03-31 $2.33B $1.58B 67.77%
2019-12-31 $2.31B $1.76B 76.04%
2019-09-30 $2.31B $0.38B 16.31%
2019-06-30 $2.29B $0.90B 39.49%
2019-03-31 $2.29B $0.57B 25.00%
2018-12-31 $2.29B $0.37B 15.94%
2018-09-30 $2.29B $1.28B 55.67%
2018-06-30 $2.28B $1.03B 45.12%
2018-03-31 $2.21B $0.77B 34.67%
2017-12-31 $2.16B $0.12B 5.65%
2017-09-30 $2.11B $0.02B 0.76%
2017-06-30 $2.09B $0.01B 0.58%
2017-03-31 $2.10B $0.03B 1.19%
2016-12-31 $2.07B $0.03B 1.21%
2016-09-30 $2.07B $0.09B 4.55%
2016-06-30 $2.03B $0.09B 4.58%
2016-03-31 $2.02B $0.10B 5.10%
2015-12-31 $2.02B $0.11B 5.40%
2015-09-30 $2.05B $0.10B 4.98%
2015-06-30 $2.11B $0.10B 4.60%
2015-03-31 $2.14B $0.10B 4.72%
2014-12-31 $2.18B $0.09B 4.14%
2014-09-30 $2.18B $0.08B 3.72%
2014-06-30 $2.15B $0.06B 2.88%
2014-03-31 $2.14B $0.07B 3.03%
2013-12-31 $2.13B $0.08B 3.66%
2013-09-30 $2.10B $0.09B 4.33%
2013-06-30 $2.10B $0.14B 6.72%
2013-03-31 $2.08B $0.15B 7.39%
2012-12-31 $2.07B $0.17B 7.97%
2012-09-30 $2.05B $0.18B 8.90%
2012-06-30 $2.06B $0.19B 8.97%
2012-03-31 $2.08B $0.18B 8.53%
2011-12-31 $2.07B $0.18B 8.63%
2011-09-30 $2.06B $0.19B 9.09%
2011-06-30 $2.01B $0.19B 9.24%
2011-03-31 $1.96B $0.18B 9.39%
2010-12-31 $1.93B $0.19B 9.65%
2010-09-30 $1.89B $0.16B 8.26%
2010-06-30 $1.88B $0.15B 7.99%
2010-03-31 $1.84B $0.15B 8.17%
2009-12-31 $1.78B $0.15B 8.13%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.121B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.383B 9.82
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
Myovant Sciences (MYOV) United Kingdom $0.879B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00